In the US, Zonegran (zonisamide systemic) is a member of the drug class carbonic anhydrase inhibitor anticonvulsants and is used to treat Benign Essential Tremor, Migraine Prevention, Parkinsonian Tremor and Seizures.
Ingredient matches for Zonegran
Zonisamide is reported as an ingredient of Zonegran in the following countries:
- United Kingdom
- United States